Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study | Zendy

Sophie Seang | Zendy; Slim Fourati | Zendy; Yamoussa Keita | Zendy; Catherine Blanc | Zendy; Roland Tubiana | Zendy; L Schneider | Zendy; M.A. Valantin | Zendy; Fabienne Caby | Zendy; Ruxandra Câlin | Zendy; Sidonie Lambert-Niclot | Zendy; AnneGeneviève Marcelin | Zendy; Vincent Cálvez | Zendy; Dominique Costagliola | Zendy; Christine Katlama | Zendy

Open Access

Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study

Author(s) -

Sophie Seang,

Slim Fourati,

Yamoussa Keita,

Catherine Blanc,

Roland Tubiana,

L Schneider,

M.A. Valantin,

Fabienne Caby,

Ruxandra Câlin,

Sidonie Lambert-Niclot,

AnneGeneviève Marcelin,

Vincent Cálvez,

Dominique Costagliola,

Christine Katlama

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku265

Subject(s) - nucleoside reverse transcriptase inhibitor , virology , reverse transcriptase , reverse transcriptase inhibitor , nucleoside , human immunodeficiency virus (hiv) , viral load , medicine , biology , antiretroviral therapy , rna , biochemistry , gene

To evaluate whether a dual nucleoside reverse transcriptase inhibitor (NRTI) strategy can control HIV replication in antiviral therapy (ART)-naive HIV-infected patients with a high CD4 cell count and a low viral load (VL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research